Skip to main content
. Author manuscript; available in PMC: 2016 Sep 6.
Published in final edited form as: Gynecol Oncol. 2015 Jun 24;138(3):566–572. doi: 10.1016/j.ygyno.2015.06.029

Table 3. Primary Treatment Characteristics.

N (%)
Initial Treatment Characteristics
 Surgery 92 (99%)
 Chemotherapy 85 (92%)
  Chemotherapy regimen
   BEP 67 (79%)
   Carboplatin-containing 12 (14%)
   EP 4 (4%)
   Other** 2 (3%)
  Number of cycles of chemotherapy
   1-2 4 (5%)
   3 33 (39%)
   4 43 (51%)
   >4 5 (6%)
Modified Pre-chemotherapy IGCCCG Group (n=85)
 Good 49 (58%)
 Intermediate 12 (14%)
 Poor 11 (13%)
 Unable to classify 13 (15%)
Modified Preoperative IGCCCG Group (n=84)*
 Good 27 (32%)
 Intermediate 9 (11%)
 Poor 13 (15%)
 Unable to classify 35 (42%)

Abbreviations: BEP, bleomycin, etoposide, and carboplatin; IGCCCG, International Germ Cell Cancer Collaborative Group

*

One patient not included because she did not undergo primary surgery prior to chemotherapy

**

Other regimens included FOLFOX and ifosfamide/Adriamycin (in patients with teratoma with malignant transformation to gastrointestinal type and sarcoma type tumors, respectively)